Similar to the first CRISPR screen, the second CRISR screen demonstrated that the selection of Chek2 KO glioma cells over time is specific to WT mice and is absent in CD8 KO mice (Fig. 2c–e). The gene discussed is CHEK2; the disease is glioma.